ATE412014T1 - Immunmodulatorische konstrukte und deren verwendungen - Google Patents

Immunmodulatorische konstrukte und deren verwendungen

Info

Publication number
ATE412014T1
ATE412014T1 AT03733654T AT03733654T ATE412014T1 AT E412014 T1 ATE412014 T1 AT E412014T1 AT 03733654 T AT03733654 T AT 03733654T AT 03733654 T AT03733654 T AT 03733654T AT E412014 T1 ATE412014 T1 AT E412014T1
Authority
AT
Austria
Prior art keywords
relates
immunomodulators
immunomodulatory constructs
immunomodulatory
constructs
Prior art date
Application number
AT03733654T
Other languages
English (en)
Inventor
John David Fraser
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Application granted granted Critical
Publication of ATE412014T1 publication Critical patent/ATE412014T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03733654T 2002-06-04 2003-06-04 Immunmodulatorische konstrukte und deren verwendungen ATE412014T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ519371A NZ519371A (en) 2002-06-04 2002-06-04 Immunomodulatory constructs and their uses

Publications (1)

Publication Number Publication Date
ATE412014T1 true ATE412014T1 (de) 2008-11-15

Family

ID=29707821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733654T ATE412014T1 (de) 2002-06-04 2003-06-04 Immunmodulatorische konstrukte und deren verwendungen

Country Status (9)

Country Link
US (1) US7547769B2 (de)
EP (1) EP1532177B1 (de)
JP (1) JP2005528100A (de)
AT (1) ATE412014T1 (de)
AU (1) AU2003238740B2 (de)
CA (1) CA2488234A1 (de)
DE (1) DE60324285D1 (de)
NZ (1) NZ519371A (de)
WO (1) WO2003101173A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491402B2 (en) * 1998-12-24 2009-02-17 Auckland Uniservices Limited Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof
US7816659B2 (en) * 2005-11-23 2010-10-19 Sandisk 3D Llc Devices having reversible resistivity-switching metal oxide or nitride layer with added metal
CA2676143A1 (en) * 2007-01-26 2008-07-31 University Of Louisville Research Foundation, Inc. Modification of exosomal components for use as a vaccine
EP2235196A4 (de) 2008-01-24 2011-09-28 Medigen Biotechnology Corp Verfahren und vorrichtungen für konvektive polymerasekettenreaktion (pcr)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US6042837A (en) * 1989-09-20 2000-03-28 Kalland; Terje Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
US6126945A (en) * 1989-10-03 2000-10-03 Pharmacia Ab Tumor killing effects of enterotoxins, superantigens, and related compounds
US5728388A (en) * 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
US6197299B1 (en) * 1990-07-20 2001-03-06 Pharmacia & Upjohn Ab Antibody conjugates
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
WO1993014634A1 (en) 1992-01-28 1993-08-05 National Jewish Center For Immunology And Respiratory Medicine Protective effects of mutated superantigens
US5545716A (en) * 1992-09-08 1996-08-13 University Of Florida Superantigen agonist and antagonist peptides
US5519114A (en) * 1993-10-29 1996-05-21 University Of Florida Research Foundation, Inc. Retroviral superantigens, superantigen peptides, and methods of use
SE9402430L (sv) 1994-07-11 1996-01-12 Pharmacia Ab Konjugat mellan modifierat superantigen och en målsökande förening samt användning av konjugaten
US5698679A (en) * 1994-09-19 1997-12-16 National Jewish Center For Immunology And Respiratory Medicine Product and process for targeting an immune response
DE19533118C1 (de) * 1995-09-07 1996-11-28 Siemens Ag Sortiereinrichtung, insbesondere für Postgut
SE9601245D0 (sv) * 1996-03-29 1996-03-29 Pharmacia Ab Chimeric superantigens and their use
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
US6340461B1 (en) * 1996-12-17 2002-01-22 David Stephen Terman Superantigen based methods and compositions for treatment of diseases
CA2356755A1 (en) 1998-12-24 2000-07-06 Auckland Uniservices Limited Superantigens
WO2002011619A1 (fr) 2000-08-04 2002-02-14 Olympus Optical Co., Ltd. Echantillonneur, procede de prelevement et procede de transplantation de substance
DE60139954D1 (de) 2000-12-04 2009-10-29 Auckland Uniservices Ltd Immunmodulatorische konstruktionen und ihre verwendung

Also Published As

Publication number Publication date
AU2003238740A1 (en) 2003-12-19
JP2005528100A (ja) 2005-09-22
US7547769B2 (en) 2009-06-16
WO2003101173A3 (en) 2004-03-04
EP1532177B1 (de) 2008-10-22
CA2488234A1 (en) 2003-12-11
DE60324285D1 (de) 2008-12-04
EP1532177A2 (de) 2005-05-25
EP1532177A4 (de) 2005-08-24
NZ519371A (en) 2004-11-26
WO2003101173A2 (en) 2003-12-11
AU2003238740B2 (en) 2009-04-09
US20060246067A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2005056759A3 (en) Methods of generating variant proteins with increased host string content and compositions thereof
EP1594536A4 (de) Adjuvante influenza-vakzine
DK1545597T3 (da) Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
TW200732349A (en) Anti-OX40L antibodies and methods using same
CY1108344T1 (el) Φορεις εκφρασης που περιεχουν τον mcmv ie2 υποκινητη
EA200701918A1 (ru) Белок липокалин
WO2005066151A3 (en) Histone deacetylase inhibitors
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
WO2003101397A3 (en) Tetravalent dengue vaccines
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
BRPI0606687A2 (pt) composições nutracêuticas
DE69937890D1 (de) Impfstoffe gegen neurotoxine von clostridium botulinum
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
ATE393796T1 (de) Härtbare zusammensetzungen auf basis von epoxidharzen und 3(4)-(aminomethyl)-cyclohexan- propanamin und 1,4(5)-cyclooctandimethanamin
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2007045019A3 (en) Polyoleosins
DK1762219T3 (da) Fotoprotektive og/eller fotoimmunprotektive sammensætninger til huden samt anvendelser deraf
ATE412014T1 (de) Immunmodulatorische konstrukte und deren verwendungen
ATE498018T1 (de) Nachweis von salmonella-lactose+
WO2007081301A3 (en) Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii
EP1626987A4 (de) Hirschgeweihextrakt zur förderung der angiogenese
WO2003093416A3 (en) Protective antigens for the control of ixodes species infestations
WO2007073567A3 (en) Compositions and methods of modulating the immune response

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties